Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 May 4;90(9):1704-6.
doi: 10.1038/sj.bjc.6601789.

Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer

L M Forrest  1 , D C McMillan, C S McArdle, W J Angerson, D J Dunlop
Affiliations
Comparative Study

Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer

L M Forrest et al. Br J Cancer. .

Abstract

The value of an inflammation-based prognostic score (GPS) was compared with performance status (ECOG) in patients (n=109) receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. On multivariate analysis with ECOG, white cell count and the GPS entered as covariates, only the GPS was a significant independent predictor of survival (HR 1.88, 95% CI 1.25-2.84, P=0.002).

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) The relationship between ECOG performance status (0 ……., 1 —–, 2 _____) in patients with inoperable non-small-cell lung cancer receiving platinum-based chemotherapy. (B) The relationship between the GPS (0 ……., 1 —–, 2 _____) in patients with inoperable non-small-cell lung cancer receiving platinum-based chemotherapy.
See this image and copyright information in PMC

References

    1. Ando M, Ando Y, Hasegawa Y, Shimokata K, Minami H, Wakai K, Ohno Y, Sakai S (2001) Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer. Br J Cancer 85: 1634–1639 - PMC - PubMed
    1. Bennett M, Ryall N (2000) Using the modified Barthel index to estimate survival in cancer patients in hospice: observational study. BMJ 321(7273): 1381–1382 - PMC - PubMed
    1. Chlebowski RT, Palomares MR, Lillington L, Grosvenor M (1996) Recent implications of weight loss in lung cancer management. Nutrition 12(1 Suppl): S43–7 - PubMed
    1. Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ (2003) Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 89: 1028–1030 - PMC - PubMed
    1. Ikeda M, Natsugoe S, Ueno S, Baba M, Aikou T (2003) Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma. Ann Surg 238: 197–202 - PMC - PubMed

Publication types

MeSH terms